Migraine with aura and risk of cardiovascular and all cause mortality in men and women: Prospective cohort study

BMJ (Online)

Volumn 341, Issue 7771, 2010, Pages 493-

  Gudmundsson, Larus S ^a   Scher, Ann I ^b   Aspelund, Thor ^a,c   Eliasson, Jon H ^d   Johannsson, Magnus ^a   Thorgeirsson, Gudmundur ^a,e   Launer, Lenore ^f   Gudnason, Vilmundur ^a,c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

^d Reykjalundur Rehabilitation Center   (Iceland)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CORONARY RISK; FEMALE; FOLLOW UP; HEADACHE; HUMAN; ICELAND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; ICELAND; MALE; MIDDLE AGED; MIGRAINE WITH AURA; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 77956269455     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3966     Document Type: Article

References (42)

1. Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005;4:533-42.
2. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-34.
3. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007;167:795-801. (Pubitemid 46658337)
4. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-91.
5. Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, Eiriksdottir G, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009;301:2563-70.
6. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914.
7. Gudmundsson LS, Aspelund T, Scher AI, Thorgeirsson G, Johannsson M, Launer LJ, et al. C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 2009;29:1301-10.
8. Gudmundsson LS, Thorgeirsson G, Sigfusson N, Sigvaldason H, Johannsson M. Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik Study. Cephalalgia 2006;26:436-44.
9. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-20.
10. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2008;28:49-56.
11. Waters WE, Campbell MJ, Elwood PC. Migraine, headache, and survival in women. BMJ 1983;287:1442-3.
12. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004;62:563-8.
13. Liew G, Wang JJ, Mitchell P. Migraine and coronary heart disease mortality: a prospective cohort study. Cephalalgia 2007;27:368-71.
14. Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache 2004;44:642-51.
15. Jonsdottir LS, Sigfusson N, Gudnason V, Sigvaldason H, Thorgeirsson G. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk 2002;9:67-76.
16. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med 1995;122:96-102.
17. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004;24(suppl 1):9-160S.
18. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
19. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
20. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
21. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41.
22. Aalen OO. Non parametric inference for a family of counting processes. Ann Stat 1978;6:701-26.
23. Nelson W. Theory and applications of hazard plotting for censored failure data. Technometrics 1972;14:945-66.
24. Kurth T, Schurks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009;73:581-8.
25. Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210. (Pubitemid 46354128)
26. Ulmer H, Kelleher C, Diem G, Concin H. Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring and Promotion Programme. Eur Heart J 2003;24:1004-13.
27. Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology 2006;67:246-51.
28. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, et al. Migraine and cardiovascular disease. A population-based study. Neurology 2010;74:628-35.
29. Olafsdottir E, Aspelund T, Sigurdsson G, Thorsson B, Benediktsson R, Harris T, et al. [Life expectancy of subjects with type two diabetes compared to others 1967-2007.] Abstract. Laeknabladid 2009;58:65.
30. Sigfusson N, Sigurdsson G, Aspelund T, Gudnason V. [The health risk associated with smoking has been seriously underestimated. The Reykjavik Study.] Laeknabladid 2006;92:263-9.
31. Del Zotto E, Pezzini A, Giossi A, Volonghi I, Padovani A. Migraine and ischemic stroke: a debated question. J Cerebr Blood F Met 2008;28:1399-421.
32. Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser MG. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004;61:1237-40. (Pubitemid 39062677)
33. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-8. (Pubitemid 14021826)
34. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004;127:212-9. (Pubitemid 38055360)
35. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006;59:372-5.
36. Henrich JB, Sandercock PA, Warlow CP, Jones LN. Stroke and migraine in the Oxfordshire community stroke project. J Neurol 1986;233:257-62.
37. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008;337:a636.
38. Lee ST, Chu K, Jung KH, Kim DH, Kim EH, Choe VN, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008;70:1510-7.
39. Tietjen GE. Migraine as a systemic vasculopathy. Cephalalgia 2009;29:987-96.
40. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007;68:1563-70.
41. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl JMed 2003;348:593-600. (Pubitemid 36204953)
42. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007. (Pubitemid 41262334)